drugset
drugset / Trial / NCT01055964

a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients

NCT01055964 ↗

Phase 3 Completed 80 enrolled Seoul National University Hospital
RandomizedCrossoverOpen-label

Summary

The aim of this study is to identify the pharmacokinetic differences between two oral forms of Tacrolimus and consequent nephrotoxicity.

Timeline

Start
2008-09
Primary completion
2014-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — Oral

Indications

No indication recorded.